Treatment resistant depression Trials in Orlando, United States
Conditions / Treatment resistant depression / Orlando, United States
Treatment resistant depression is a medical condition with active clinical research programs worldwide.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02417064 | A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression | COMPLETED | PHASE3 |
| NCT03887715 | A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression | RECRUITING | NA |
| NCT04608396 | Mechanistic Evaluation of Response in TRD (MERIT) | COMPLETED | PHASE2 |
| NCT04634669 | Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE) | TERMINATED | PHASE2 |
| NCT04039022 | Open-Label Safety Study of AXS-05 in Subjects With Depression | COMPLETED | PHASE3 |
| NCT04663321 | Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006) | TERMINATED | PHASE2 |
| NCT05711940 | Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04753385 | The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes | TERMINATED | — |
| NCT05113771 | A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD | COMPLETED | PHASE2 |
| NCT05624268 | Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD | ACTIVE_NOT_RECRUITING | PHASE3 |